CanFite BioPharma Company

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.
Technology: P4 Medicine
Industry: Personalized Medicine
Headquarters: Petah Tiqva, Israel
Founded Date: 1994
Employees Number: 1-10
Funding Status: IPO
Investors Number: 4
Total Funding: $51.4M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
info@canfite.co.il
Register and Claim Ownership